menu
    • menu
    [{"orgOrder":0,"company":"FEMPHARMA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"HUNGARY","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Cortexium","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"FEMPHARMA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"FEMPHARMA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"FEMPHARMA \/ Undisclosed"},{"orgOrder":0,"company":"FEMPHARMA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"HUNGARY","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Incoxil Food Supplement","moa":"Undisclosed","graph1":"Urology","graph2":"Undisclosed","graph3":"FEMPHARMA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"FEMPHARMA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"FEMPHARMA \/ Undisclosed"},{"orgOrder":0,"company":"FEMPHARMA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Hormone","year":"2023","type":"Inapplicable","leadProduct":"Juvia","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"FEMPHARMA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Gel","sponsorNew":"FEMPHARMA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"FEMPHARMA \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by FEMPHARMA

    Menu

    FEMPHARMA

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cortexium

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Cognitive Effects of a Dietary Supplement with PQQ, GABA, Caffeine, and B-Vitamins in Healthy Postmenopausal W...

                            Details : Cortexium is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            December 27, 2024

                            Lead Product(s) : Cortexium

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Juvia

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.

                            Details : Juvia is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Candidiasis, Vulvovaginal.

                            Product Name : Undisclosed

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            June 08, 2023

                            Lead Product(s) : Juvia

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed

                            FEMPHARMA

                            Hungary arrow
                            Pharma MES 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Incoxil Food Supplement

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study of Incoxil Food Supplement in Female Patients With Stress Dominant Urinary Incontinence.

                            Details : Incoxil Food Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Urinary Incontinence.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            May 03, 2022

                            Lead Product(s) : Incoxil Food Supplement

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth